91 results
8-K
EX-99.2
ANGO
Angiodynamic Inc
4 Apr 24
Results of Operations and Financial Condition
7:30am
include, without limitation, the scale and scope of the COVID-19 global pandemic, the ability of AngioDynamics to develop its existing and new products
8-K
EX-99.1
ANGO
Angiodynamic Inc
4 Apr 24
Results of Operations and Financial Condition
7:30am
that may affect the actual results achieved by AngioDynamics include, without limitation, the scale and scope of the COVID-19 global pandemic
8-K
ANGO
Angiodynamic Inc
4 Apr 24
Results of Operations and Financial Condition
7:30am
and scope of the COVID-19 global pandemic, the ability of AngioDynamics to develop its existing and new products, technological advances and patents
8-K
ANGO
Angiodynamic Inc
11 Jan 24
Regulation FD Disclosure
7:30am
of the COVID-19 global pandemic, the ability of AngioDynamics to develop its existing and new products, technological advances and patents attained
8-K
EX-99.1
ANGO
Angiodynamic Inc
5 Jan 24
AngioDynamics Reports Fiscal Year 2024 Second Quarter
7:15am
and scope of the COVID-19 global pandemic, the ability of AngioDynamics to develop its existing and new products, technological advances and patents
8-K
54tu pgr5afdjkcg
5 Jan 24
AngioDynamics Reports Fiscal Year 2024 Second Quarter
7:15am
8-K
EX-99.2
03hma5stqyfg9hh64
5 Jan 24
AngioDynamics Reports Fiscal Year 2024 Second Quarter
7:15am
8-K
EX-99.1
233h 7jdlvsg
4 Oct 23
Results of Operations and Financial Condition
7:15am
8-K
EX-99.2
tvi1bldjue lsspt
4 Oct 23
Results of Operations and Financial Condition
7:15am
8-K
tqzen cdm
4 Oct 23
Results of Operations and Financial Condition
7:15am
8-K
EX-99.1
8kgfif
12 Jul 23
Results of Operations and Financial Condition
7:30am
8-K
EX-99.2
m7mtmuh9cpp7 mm
12 Jul 23
Results of Operations and Financial Condition
7:30am
8-K
rans1lou rcdy
12 Jul 23
Results of Operations and Financial Condition
7:30am
8-K
EX-2.1
84bhsmrrpl kpkqv
14 Jun 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:39pm
8-K
EX-99.1
cvqd3m ama2ss3ucorzn
8 Jun 23
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
5:05pm
8-K
omd3z
2 Jun 23
Other Events
7:00am
8-K
z52gs2u8
17 Apr 23
Regulation FD Disclosure
7:21am
8-K
EX-99.1
lbb1jtx6k yewka30i
17 Apr 23
Regulation FD Disclosure
7:21am